Menu
Okogen specializes in developing treatments which drastically accelerate viral clearance of adenoviral conjunctivitis and improve symptoms.
Viral conjunctivitis (a subtype of acute conjunctivitis), which may also be known as pink eye, is a serious ophthalmic infection with potential long-term negative effects.
Viral conjunctivitis results in moderate to severe inflammation of the conjunctiva, the mucous membrane that covers the front of the eye and lines the inside of the eyelids.
Corneal opacity occurs in 20-50% of viral conjunctivitis cases, and can lead to scarring or clouding of the cornea. Significantly, this may result in long-term visual impairment and premature/chronic dry eye.
Signs and symptoms of viral conjunctivitis include eye pain, redness, swelling and discharge, which cause significant discomfort and embarrassment.
Currently it takes 2-3 weeks to resolve without treatment. OKG-0502 will significantly shorten the infection and associated symptoms.
Virus causes conjunctivitis via replication in infected cells
The anti-viral preferentially enters virally infected cells and inhibits viral replication
The anti-viral inhibits viral replication and the ocular decongestant reduces redness & discharge
© 2021 Okogen, Inc. All Rights Reserved
United States
Okogen, Inc.
332 Encinitas Blvd. Suite 102
Encinitas, CA 92024, USA
Australia
Okogen Pty Ltd
Level 9, 31 Queen St
Melbourne, VIC 3000 AUS
